Potential PTSD biomarkers extend beyond monoamines to include abnormalities in GABA, neuropeptides, BDNF, HPA-axis dysregulation, and inflammatory cytokines (49, 50). The gene discussed is BDNF; the disease is post-traumatic stress disorder.